Thousands Of Adverse Medical Events Reported After Taking Coronavirus Vaccines Including Death, Heart Attacks And Strokes Confirming Previous Site Claims

Thousands Of Adverse Medical Events Reported After Taking Coronavirus Vaccines Including Death, Heart Attacks And Strokes Confirming Previous Site Claims

December 29. 2020

Pfizer

This is a follow up to several articles I've written on this site about the dangers of the coronavirus vaccines (see "RELATED ARTICLES" section below). Since the vaccinations began over the past 3-weeks, there have been many reports of adverse medical events. In December the public learned several people died during the Pfizer trial. Two people died during the AstraZeneca trial.

When the vaccines were rolled out, people all over the world reported cases of anaphylactic shock, which can turn fatal if medicine is not immediately administered to counteract the effects of said allergic reaction to the vaccines.

Report reveals 3,150 adverse "health impact events"

There are 3,150 reports of adverse medical events associated with the coronavirus vaccines. One man in Israel even died of a heart attack after receiving the coronavirus vaccine. Some people have also developed Bells Palsy. The FDA issued a warning of "severe adverse reactions" after taking the second dose of the Pfizer vaccine.

The Egypt Independent reported, "The FDA added that two participants died from heart attacks or stroke, and the cause of death of two others is still being determined." This confirms my previous statements on Twitter.com from July 25, 2020 regarding the then unreleased vaccines potential to cause heart attacks, strokes and death, which has happened now 5-months later:

STORY SOURCE

FDA: Six people die during Pfizer/BioNTech’s coronavirus vaccine trials

December 9, 2020 2:16 pm - Six people died during trials of the coronavirus vaccine produced by the American pharmaceutical company “Pfizer” and the German “BioNTech” company, the US Food and Drug Administration (FDA) said on Wednesday.

In a statement released by US channel Al-Hurra, the FDA confirmed that among the deceased was a participant who was obese and suffering from arteriosclerosis and died three days after taking the first dose of the vaccine.

The FDA added that two participants died from heart attacks or stroke, and the cause of death of two others is still being determined. “Of the six dead, three are over the age of 55,” the FDA clarified. According to Pfizer’s website, Phase Three of the clinical trials included a total of 43,538 participants.

The FDA previously confirmed the vaccine’s 95 percent efficacy rate, and supporting documents have proven that the drug is safe and may be used for emergency situations. The American biotechnology company Moderna said in December that it had submitted a request to the FDA to obtain a license for emergency use of its vaccine, less than a year after it began its clinical trials.

Moderna was the second company to request emergency approval from the FDA, just two weeks after Pfizer and BioNTech. If Moderna successfully obtains permission from the FDA, it can begin giving doses of its vaccine on December 21.

Moderna previously announced that its vaccine against the coronavirus was 100 percent effective against severe cases of the virus – a significant leap in COVID-19 vaccine development. Moderna joins Pfizer/BioNTech, Russsia’s Sputnik V, and Oxford/AstraZeneca as the most successful coronavirus vaccine manufacturers in the world as of now...

https://egyptindependent.com

FDA Says 2 Participants In Pfizer COVID Vaccine Trial Have Died

Tuesday, Dec 08, 2020 - 13:30 - With the FDA expected to grant emergency-use approval for the Pfizer-BionTech COVID vaccine Thursday after releasing a preliminary assessment of the trial data that the panel will use to assess the drug earlier today, the agency has admitted Tuesday that two participants in the Phase 3 trials have died. One of them was immunocompromised, according to the Jerusalem Post, citing data released earlier.

The FDA is expected to release two separate assessments of the trial data before a panel of experts meets to review the data and either approve Pfizer's request for emergency approval, or deny it. This also comes after the FDA warned of a "severe averse reaction" frequently seen in patients after taking the second dose.

In the US, there has been at least one other trial participant who reportedly died not long after receiving the second dose. The participant in that case was a priest in Philadelphia who participated in the Moderna trial. In the UK, two patients were seriously sickened during the trial of the AstraZeneca-Oxford vaccine (though Oxford later said the illnesses had nothing to do with the trial). While In Brazil, authorities briefly halted a trial of Sinovac's experimental COVID vaccine after a participant died...

https://www.zerohedge.com

FDA Confirms Pfizer Vaccine 95% Effective, Warns Of 'Severe Adverse Reactions' After Dose 2

Tuesday, Dec 08, 2020 - 8:07 - Pfizer and partner BioNTech’s COVID-19 vaccine meets expectations on agency guidance and is enough to spur an agency review, according to staff of the U.S. Food and Drug Administration.

The finding is one of several significant new results featured in the briefing materials, which span 53 pages of data analyses from the agency and from Pfizer. On Thursday, F.D.A.’s vaccine advisory panel will discuss these materials in advance of a vote on whether to recommend authorization...

https://www.zerohedge.com

Fairbanks clinician is third Alaskan with adverse reaction to COVID-19 vaccine

Saturday, 19 December 2020 00:46 GMT - ANCHORAGE, Alaska, Dec 18 (Reuters) - A Fairbanks clinician suffered anaphylactic symptoms after being given the Pfizer Inc coronavirus vaccine, a hospital said on Friday, becoming the third Alaska health care worker to suffer an adverse reaction to the new drug.

The clinician, whose name was not released, started showing symptoms about 10 minutes after being inoculated on Thursday, according to Foundation Health Partners, operator of the Fairbanks Memorial Hospital. The health care worker was treated in the hospital's emergency room with epinephrine and released about six hours later, Foundation Health Partners said in a written statement.

Two health care workers in Juneau suffered adverse reactions to the medication earlier this week. One was briefly hospitalized in that city for anaphylaxis after she was vaccinated on Tuesday. The second had a milder reaction on Wednesday and was treated at the hospital emergency room and released...

https://news.trust.org

UK issues anaphylaxis warning on Pfizer vaccine after adverse reactions

December 9, 202010:31 PM - LONDON (Reuters) - Britain’s medicine regulator said anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving fuller guidance on an earlier allergy warning about the shot.

Starting with the elderly and frontline workers, Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history. The Medicines and Healthcare Products Regulatory Agency (MHRA) said there had been two reports of anaphylaxis and one report of a possible allergic reaction since rollout began.

“Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine,” MHRA Chief Executive June Raine said in a statement. “Most people will not get anaphylaxis and the benefits in protecting people against COVID-19 outweigh the risks... You can be completely confident that this vaccine has met the MHRA’s robust standards of safety, quality and effectiveness.”

Anaphylaxis is an overreaction of the body’s immune system, which the National Health Service describes as severe and sometimes life-threatening. The fuller guidance, clarifying that the main risk was from anaphylaxis specifically, was issued after consulting experts on allergies. The MHRA had initially advised anyone with a history of a “significant allergic reaction” not to take the shot...

https://www.reuters.com

Oxford coronavirus vaccine results leave regulators with 'dilemma', warns scientist

Tue, December 8, 2020, 10:25 AM EST - The Oxford vaccine may not be as useful as first thought, after published results showed that high efficacy rates cannot be substantiated. At the end of November, Oxford and AstraZeneca announced they had efficacy rates of 90 per cent when people were given a half dose, followed by a full dose several weeks later.

However when people received two full doses, efficacy fell to just 62 per cent, far lower than the mid-90s results shown by Pfizer and Moderna. The results leave regulators with a "dilemma", scientists have warned. The Oxford data is currently being studied by the Medicines and Healthcare products Regulatory Agency (MHRA) which will decide whether to approve the jab. However, new data published in The Lancet on Tuesday has led to fears that the more effective half-dose regime will not be approved...

https://www.yahoo.com

Thousands Negatively Affected After Getting Covid-19 Vaccine

https://www.theepochtimes.com

RELATED ARTICLES

China And New York Hospitals Using Vitamin C To Aid In Treating Coronavirus Patients (Confirming Previous Claims)

Reports Confirm Obesity And Compromised Immune System Linked To Severity Of Coronavirus Infections As Previously Stated On The Site

Scientists Confirm 8 Coronavirus Strains Are Circling The Globe As Previously Stated On The Site (Covid-19)

New Scientific Study Confirms Coronavirus Sufferers Having Difficulty Expelling CO2 As Previously Stated On The Site

Coronavirus Infection Rate Skyrockets Among American Kids With The Reopening Of Schools As Previously Predicted On The Site

Britain Death Toll From Coronavirus Becomes The Highest In Europe Due To Prime Minister Boris Johnson's Failed Herd Immunity Strategy

Theresa May And Boris Johnson Under-Funding Of The NHS Left The Health Service Ill-Prepared To Counter The Effects Of The Coronavirus (Covid-19)

Man In Hong Kong Contracts Coronavirus For A Second Time Confirming Previous Site Claims (Video)